PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15748179

Module five: implementation of ethics review.

Ames Dhai
View original source ↗Export metadata ↓

Abstract

The objective of this module is to inform you on issues of concern for Research Ethics Committee members and investigators during the review process. The many guidelines on research ethics, including those from the South African Department of Health and the World Health Organisation, will be referred to extensively to educate you on the requirements of Research Ethics Committees. The evolution of the review process in South Africa will be detailed.

Explore related subjects

Advisory CommitteesBehavioral ResearchClinical Trials Data Monitoring CommitteesConfidentialityConflict of InterestEthical ReviewEthics Committees, ResearchFees and ChargesGuidelines as TopicHealth Services ResearchHuman ExperimentationHumansInternationalityMulticenter Studies as TopicResearch SubjectsRisk AssessmentSouth AfricaBiomedical and Behavioral ResearchJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ames Dhai. 2005. Module five: implementation of ethics review.. https://doi.org/10.1111/j.1471-8847.2005.00103.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗